Respiratory carcinogenicity assessment of soluble nickel compounds.
The many chemical forms of nickel differ in physicochemical properties and biological effects. Health assessments for each main category of nickel species are needed. The carcinogenicity assessment of water-soluble nickel compounds has proven particularly difficult. Epidemiologic evidence indicates an association between inhalation exposures to nickel refinery dust containing soluble nickel compounds and increased risk of respiratory cancers. However, the nature of this association is unclear because of limitations of the exposure data, inconsistent results across cohorts, and the presence of mixed exposures to water-insoluble nickel compounds and other confounders that are known or suspected carcinogens. Moreover, well-conducted animal inhalation studies, where exposures were solely to soluble nickel, failed to demonstrate a carcinogenic potential. Similar negative results were seen in animal oral studies. A model exists that relates respiratory carcinogenic potential to the bioavailability of nickel ion at nuclear sites within respiratory target cells. This model helps reconcile human, animal, and mechanistic data for soluble nickel compounds. For inhalation exposures, the predicted lack of bioavailability of nickel ion at target sites suggests that water-soluble nickel compounds, by themselves, will not be complete human carcinogens. However, if inhaled at concentrations high enough to induce chronic lung inflammation, these compounds may enhance carcinogenic risks associated with inhalation exposure to other substances. Overall, the weight of evidence indicates that inhalation exposure to soluble nickel alone will not cause cancer; moreover, if exposures are kept below levels that cause chronic respiratory toxicity, any possible tumor-enhancing effects (particularly in smokers) would be avoided.
Oller
Adriana R
AR
Nickel Producers Environmental Research Association, 2605 Meridian Parkway, Suite 200, Durham, NC 27713, USA. aoller@nipera.org
D000818:Animals; D001682:Biological Availability; D018929:Cell Culture Techniques; D002471:Cell Transformation, Neoplastic; D004195:Disease Models, Animal; D016021:Epidemiologic Studies; D006801:Humans; D019570:Inhalation Exposure; D007477:Ions; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000503:physiopathology; D008954:Models, Biological; D009532:Nickel / Q000009:adverse effects* / Q000737:chemistry / Q000493:pharmacokinetics; D051381:Rats; D012107:Research Design; D018570:Risk Assessment; D012907:Smoking / Q000009:adverse effects; D012995:Solubility
D007477:Ions; D009532:Nickel